SPG
41
3
AIZ
64
3
PNC
57
2
PYPL
24
2
CVX
37
3
CFG
58
4
NFLX
65
3
WMB
55
4
NOC
50
-4
AME
48
3
HIG
70
4
KMI
59
2
FAST
64
11
PX
50
4
DHR
46
3
FTI
56
16
TGNA
58
5
VNO
40
4
MKC
59
3
AVY
54
6
SPG
41
3
AIZ
64
3
PNC
57
2
PYPL
24
2
CVX
37
3
CFG
58
4
NFLX
65
3
WMB
55
4
NOC
50
-4
AME
48
3
HIG
70
4
KMI
59
2
FAST
64
11
PX
50
4
DHR
46
3
FTI
56
16
TGNA
58
5
VNO
40
4
MKC
59
3
AVY
54
6
Financhill
Back

Gold Fields Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
67

GFI
Gold Fields

Last Price:
$23.88
Seasonality Move:
-0.56%
Buy
55

SRPT
Sarepta Therapeutics

Last Price:
$54.40
Seasonality Move:
12.51%
Buy
67
Gold Fields (GFI) is a Buy

Is Gold Fields a Buy, Sell or Hold?

  • The current Gold Fields [GFI] share price is $23.69. The Score for GFI is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • GFI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
55
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $54.63. The Score for SRPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

GFI Stock Price Chart

What is Gold Fields's stock price today?

  • The Gold Fields share price today is $23.69
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GFI is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $54.63
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.

GFI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.87 Buy
Relative Strength Index (14 RSI): 62.24 Buy
Chaikin Money Flow: 3374955 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -11.68 Sell
Relative Strength Index (14 RSI): 32.09 Sell
Chaikin Money Flow: 2296392 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

GFI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 22.03 Buy
20-day SMA: 21.76 Buy
50-day SMA: 20.1 Buy
200-day SMA: 16.51 Buy
8-day EMA: 22.61 Buy
20-day EMA: 21.72 Buy
50-day EMA: 20.12 Buy
200-day EMA: 17.14 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.3 Buy
20-day SMA: 64.03 Sell
50-day SMA: 89.96 Sell
200-day SMA: 120.12 Sell
8-day EMA: 55.01 Sell
20-day EMA: 65.16 Sell
50-day EMA: 83.67 Sell
200-day EMA: 109.88 Sell

Gold Fields Earnings Growth & GFI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.16 per share, an increase next quarter of $0.02 per share, an increase this year of $0.96 per share, and an increase next year of $0.18 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.27 per share, a decrease next quarter of $0.11 per share, an increase this year of $3.98 per share, and an increase next year of $6.27 per share.

Gold Fields Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):